Research Article

Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway

Figure 7

The Rab22 promoted invasion and migration of thyroid cancer cells was weakened by PI3K inhibitors. Transwell assays showed that the migration and invasion of TPC1 and K1 cells decreased by PI3K inhibitors (a, 200×). The migration of TPC1 and K1 cells was assessed by wound healing assays (b, 200×). Statistical data were the of the three repeated independent trials: , , and .
(a)
(b)